1. Home
  2. AMLX vs CAC Comparison

AMLX vs CAC Comparison

Compare AMLX & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMLX
  • CAC
  • Stock Information
  • Founded
  • AMLX 2014
  • CAC 1875
  • Country
  • AMLX United States
  • CAC United States
  • Employees
  • AMLX N/A
  • CAC N/A
  • Industry
  • AMLX Biotechnology: Pharmaceutical Preparations
  • CAC Major Banks
  • Sector
  • AMLX Health Care
  • CAC Finance
  • Exchange
  • AMLX Nasdaq
  • CAC Nasdaq
  • Market Cap
  • AMLX 749.9M
  • CAC 680.5M
  • IPO Year
  • AMLX 2022
  • CAC 1997
  • Fundamental
  • Price
  • AMLX $13.48
  • CAC $38.46
  • Analyst Decision
  • AMLX Strong Buy
  • CAC Buy
  • Analyst Count
  • AMLX 7
  • CAC 3
  • Target Price
  • AMLX $15.14
  • CAC $48.00
  • AVG Volume (30 Days)
  • AMLX 2.0M
  • CAC 66.6K
  • Earning Date
  • AMLX 11-06-2025
  • CAC 10-28-2025
  • Dividend Yield
  • AMLX N/A
  • CAC 4.37%
  • EPS Growth
  • AMLX N/A
  • CAC 4.80
  • EPS
  • AMLX N/A
  • CAC 3.11
  • Revenue
  • AMLX N/A
  • CAC $197,501,000.00
  • Revenue This Year
  • AMLX N/A
  • CAC $42.11
  • Revenue Next Year
  • AMLX N/A
  • CAC $5.51
  • P/E Ratio
  • AMLX N/A
  • CAC $12.35
  • Revenue Growth
  • AMLX N/A
  • CAC 21.74
  • 52 Week Low
  • AMLX $2.60
  • CAC $34.53
  • 52 Week High
  • AMLX $15.15
  • CAC $50.07
  • Technical
  • Relative Strength Index (RSI)
  • AMLX 61.47
  • CAC 46.25
  • Support Level
  • AMLX $12.35
  • CAC $37.50
  • Resistance Level
  • AMLX $13.75
  • CAC $39.54
  • Average True Range (ATR)
  • AMLX 0.82
  • CAC 0.86
  • MACD
  • AMLX -0.22
  • CAC -0.08
  • Stochastic Oscillator
  • AMLX 41.86
  • CAC 31.13

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

Share on Social Networks: